A Pilot Study to Explore the Role of Gut Flora in Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- N/A
Clinical Trials Related to Colorectal Cancer
Related studies linked through entity extraction aliases.
Faecal Immunochemical Test and Urine Volatile Compounds in Adenoma Detection
- Status
- COMPLETED
- Phase
- N/A
Micrometastases and Angiogenesis in Colon Cancer. Prognostic Value of VEGF.
- Status
- UNKNOWN
- Phase
- N/A
Family History Study on Cancer Risk
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Protein Needs Study
- Status
- RECRUITING
- Phase
- NA
Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: "Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C"
- Status
- COMPLETED
- Phase
- N/A
Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening "BLUE-C"
- Status
- COMPLETED
- Phase
- N/A
Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Perioperative Immune Function in Patients Undergoing Colorectal Cancer Surgery
- Status
- UNKNOWN
- Phase
- N/A
Study on the Effectiveness and Safety of the Combination of the Two Drugs Regorafenib and Nivolumab in Patients With Colorectal Cancer (Cancer of the Colon or Rectum Classified as Proficient Mismatch Repair and Microsatellite Stable)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of JAB-3312 in Adult Patients With Advanced Solid Tumors in China
- Status
- COMPLETED
- Phase
- PHASE1
ALFAOMEGA Master Observational Trial
- Status
- RECRUITING
- Phase
- N/A
A Study for PD-1 Antibody JS001 in MSI-H Advanced or Recurrent Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Pooled Mutant KRAS-Targeted Long Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Resected Mismatch Repair Protein (MMR-p) Colorectal and Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Regorafenib Plus PD-1 Inhibitor in Patients With Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid Tumour
- Status
- UNKNOWN
- Phase
- PHASE1
Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy
- Status
- TERMINATED
- Phase
- N/A
Endoscopic Optical Imaging for Precision Oncology Treatment Applied to Colorectal Tumours (Elios-Color-on-Specimen)
- Status
- WITHDRAWN
- Phase
- NA
Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Incremental Cost-Utility Study on Prehabilitation Among Older Patients With Colorectal Cancer Undergoing Surgery
- Status
- TERMINATED
- Phase
- N/A